A Senate committee held a hearing on 23andMe and concerns about customers' genetic data. The genomics company filed for bankruptcy in March, leading to concerns over a privacy policy clause that stated the company could sell personal genetic and health data for its more than 15 million customers. CBS News' Shanelle Kaul has more.
